Cytokinetics Incorporated (CYTK) Gained 5.2% or 0.4 To Price $8.2 On Monday


Cytokinetics Incorporated (CYTK) gained 5.2% or 0.4 to $8.2. It is near 373231 shares traded, which is 62.68% compare to the average total volume 595416. The market cap of CYTK is $449.81 million. The year to date change is 19.42%. The 52 week price range is from $5.75 to $10.0. Price of CYTK have changed 18.03% during last week. It have changed 1.30% over last month, 10.65% over last 3 months, -8.35% over last 6 months and -10.46% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CYTK is 7.10. It is -13.41% below current price. The 200-day Moving Averages for CYTK is 7.67. It is -6.46% below current price. The 52-week High is 10.0. It is 21.95% from the current price. The 52-week Low is 5.75. It is -29.88% from current price.

There are some statistics of CYTK. It is has market cap $449.81 million. The share outstanding is 54.89 million. The average volume is 595416. The percent of top 15 Institution holding is 105.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CYTK is -156.57%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CYTK is -42.01%.


Tags:

Share this post